295 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
INCY Incyte Corporation $67.04 $14.25B N/A
Article Searches
Read This Before You Buy Biotech Stocks https://www.fool.com/investing/2017/04/23/read-this-before-you-buy-biotech-stocks.aspx?source=iedfolrf0000001 Apr 23, 2017 - Looking to buy biotech stocks? Here are 7 important things to know.
Incyte (INCY) Up 26.2% Since Earnings Report: Can It Continue? http://www.zacks.com/stock/news/253120/incyte-incy-up-262-since-earnings-report-can-it-continue?cid=CS-ZC-FT-253120 Mar 17, 2017 - Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FDA Rejects Eli Lilly and Incyte Drug https://www.wsj.com/articles/fda-rejects-eli-lilly-and-incyte-rheumatoid-arthritis-drug-1492183825?mod=pls_whats_news_us_business_f Apr 14, 2017 - Eli Lilly and Incyte said the U.S. Food and Drug Administration didn’t approve their new drug application for a rheumatoid arthritis treatment that some analysts estimate could generate more than $2 billion in annual sales.
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain https://www.fool.com/investing/2017/04/17/lilly-and-incytes-loss-is-abbvie-and-regenerons-ga.aspx?source=iedfolrf0000001 Apr 17, 2017 - The FDA has rejected Eli Lilly and Incyte's application for approval of a potential blockbuster rheumatoid arthritis drug.
The IDO-Inhibitor Race Is On to Improve Cancer Treatment https://www.fool.com/investing/2017/04/13/the-ido-inhibitor-race-is-on-to-improve-cancer-tre.aspx?source=iedfolrf0000001 Apr 13, 2017 - NewLink Genetics and Incyte Corporation's IDO-inhibitors could be the next big advance in cancer treatment.
3 Beaten-Up Biotech Stocks: Are They Bargains? https://www.fool.com/investing/2017/08/14/3-beaten-up-biotech-stocks-are-they-bargains.aspx?source=iedfolrf0000001 Aug 14, 2017 - It's been a pretty good year for biotech, but these three stocks have tumbled. Is the pessimism overblown?
Should You Make a Bet on the Healthcare Stocks? http://www.zacks.com/stock/news/256768/should-you-make-a-bet-on-the-healthcare-stocks?cid=CS-ZC-FT-256768 Apr 18, 2017 - The healthcare industry is much more than Obamacare and drug prices as many companies are using new technologies to create breakthroughs in medicine.
Better Buy: Eli Lilly and Company vs. Pfizer Inc. https://www.fool.com/investing/2017/09/01/better-buy-eli-lilly-and-company-vs-pfizer.aspx?source=iedfolrf0000001 Sep 01, 2017 - How do Eli Lilly and Pfizer fare in a head-to-head matchup between the two big pharma stocks?
3 Top Biotech Stocks For May https://www.fool.com/investing/2017/05/11/3-top-biotech-stocks-for-may.aspx?source=iedfolrf0000001 May 11, 2017 - These three biotechs could be stellar buys this month.
4 of the Highest-Growth Stocks in Biotech Today https://www.fool.com/investing/2017/08/24/4-of-the-highest-growth-stocks-in-biotech-today.aspx?source=iedfolrf0000001 Aug 24, 2017 - How does a compound annual growth rate of 50%, 60%, or 70% sound?

Pages: 123456...30

Page 1>